4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-054284
Chief Medical Officer sold 12,500 shares at an average $41.74 ($521,795)
- Chief Medical Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-10-07 | Option exercise | +10,185 | $1.53 | $15,583 | 39,962 | D: show line 1 in the form |
| Pang Phillip Chief Medical Officer | 2020-10-07 | Option exercise | +2,315 | $1.58 | $3,646 | 42,277 | D: show line 2 in the form |
| Pang Phillip Chief Medical Officer | 2020-10-07 | Sale | −7,500 | $41.76 | $313,166 | 34,777 | D: show line 3 in the form |
| Pang Phillip Chief Medical Officer | 2020-10-07 | Sale | −5,000 | $41.73 | $208,629 | 29,777 | D: show line 4 in the form |
| Open-market sales · 12,500 sh · avg $41.74 · $521,795 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-10-07 | Option exercise · Employee Stock Option (Right to Buy) | −10,185 | 100,461 | D: show line 5 in the form | ||
| Pang Phillip Chief Medical Officer | 2020-10-07 | Option exercise · Employee Stock Option (Right to Buy) | −2,315 | 50,927 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…